Ascentage Pharma Group International ( ASPHF) - Key Metrics
ASPHF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.90 | -$1.73 | ? | ? |
| 2025Q2 | $0.68 | -$1.73 | -$1.27 | -$1.32 |
| 2024Q4 | $0.50 | -$1.82 | $0.78 | $0.75 |
| 2024Q2 | $2.78 | $0.55 | -$1.20 | -$1.25 |
| 2023Q4 | $0.27 | -$1.80 | -$1.23 | -$1.27 |
ASPHF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -6.78 |
| 2025Q2 | ? | -10.08 |
| 2024Q4 | ? | -5.86 |
| 2024Q2 | ? | 10.80 |
| 2023Q4 | ? | -3.43 |
ASPHF
Price: $4.53
52 week price:
Earnings Per Share: -0.53 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.8 billion